What is the maximum dose of ASA allowed for patients experiencing cardiac ischemia?

Aspirin, also known as acetylsalicylic acid (ASA), is widely used in the context of acute coronary syndromes, including cardiac ischemia, due to its antiplatelet properties. The goal is to reduce platelet aggregation and prevent further clot formation in the coronary arteries, which is crucial for improving outcomes in patients experiencing such events.

The recommended maximum dose of aspirin for patients experiencing cardiac ischemia is 162 mg. This dosage strikes a balance between maximizing the antiplatelet effect while minimizing the risk of side effects such as gastrointestinal bleeding, which can increase with higher doses.

Aspirin is often administered as a chewable tablet in this scenario, as it allows for faster absorption and onset of action. The chosen dose is based on clinical guidelines that recommend the use of high-dose aspirin in the acute setting to ensure effective treatment.

In summary, the correct choice of 162 mg reflects established protocols for managing patients with cardiac ischemia, emphasizing effective treatment while managing safety considerations.